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Purpose
To determine the influence of ethnicity and sociodemo-
graphic factors on disease presentation, manifestations,
disease activity, and disease outcomes, using baseline
data from the pediatric arm of the 1000 Canadian Faces
of Lupus Study, a multicenter, prospective study of the
Canadian Lupus population.
Methods
Childhood-onset SLE (<18th birthday) patients at four
pediatric centers (Halifax, Montreal, Toronto and Vancou-
ver). Collected data included sociodemographics, disease
manifestations, current/past medications, laboratory mea-
sures and multiple disease measures. The Child Health
Questionnaire (CHQ), measuring multiple domains of
health status was administered. For analysis, patients were
categorized by their primary self-selected ethnic category.
Results
Between November 2005 and February 2009, 213 cSLE
patients were enrolled. The number of patients enrolled at
each site mirrored the size of the clinical centre: Toronto
134 (63%), Vancouver 54 (25%), Montreal 17 (8%), and
Halifax 8 (4%). There were 176 (83%) females, mean age at
diagnosis was 12.5 ± 0.3 years, mean disease duration was
2.5 ± 2.7 years, and 175 patients (82%) were born in
Canada. Demographic data were similar across the geo-
graphic sites, except for a longer disease duration in Van-
couver (3.9 ± 3.6 years, p<.001). Primary self-reported
race/ethnicity data was available for 191 patients: White
(31%), Asian (30%), South Asian (15%), Black (10%),
Latino/Hispanic (4%), Aboriginal (4%) and Arab/Middle
Eastern (3%). Because of low numbers, the Latino/Hispa-
nic and Arab/Middle Eastern groups were excluded from
the analysis. Ethnic distribution across the centers differed
(p<.001), reflecting known differences in the urban popu-
lations. The distribution of household income, and pre-
scription drug plan coverage did not differ across
ethnicities, however, fewer Asians (64%) had dental insur-
ance coverage as compared to White (88%) and Aboriginal
(100%) patients (p<.01). Missed school days did not differ
by ethnicity, although 26% of the entire cohort reported
missing on average 6 days per month. CHQ scores were
lower in 7 of 10 domains in white patients vs. non-white
ethnicities (p<.05 for each). Autoantibodies and SLE classi-
fication criteria present at any time that differed by ethni-
city are listed in table 1.
Medications were prescribed equally across ethnicities;
most patients were taking prednisone (75%), hydroxy-
chloroquine (84%), and 56% required additional immuno-
suppression (azathioprine, methotrexate, mycophenolate
mofetil or cyclophosphamide). Disease measures were
similar across ethnicities, overall SLEDAI was 3.1 ± 4.2,
SLAM 3.4 ± 3.7; SDI median 0.3 (range 0-5), and physi-
cian global VAS was 15 ± 23 (range 0-99).
Conclusion
Canadian cSLE patients reflect our multi-ethnic popula-
tion, with observed differences in disease manifestations,
antibody profiles and health status by ethnicity.
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Table 1 Classification criteria by ethnicity
Criterion %present Total (n=191) Aboriginal (n=9) Asian (n=63) South Asian (n=32) Black (n=22) White (n=65) p-value
Malar rash 65 33 65 66 36 78 <0.05
Arthritis 62 78 46 72 59 71 <0.05
Serorsitis 18 44 16 16 41 11 <0.05
Renal 36 33 51 28 59 22 <0.01
Immunologic 81 100 87 97 82 65 <0.001
dsDNA 66 56 75 81 73 49 <0.01
Anti-Sm 32 56 43 22 41 20 <0.05
aPL (ACL or LAC) 47 33 49 53 55 42 NS
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